Scott Wise
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments 10
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 6
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 5
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 4
-
- Protein Kinase Regulation and GTPase Signaling 4
-
- Ferroptosis and cancer prognosis 4
-
- Musculoskeletal synovial abnormalities and treatments 3
-
- Nanoplatforms for cancer theranostics 3
- Co-authors
- Todd LeffMichael J. BirrerPowel H. BrownAnita L. SabichiDaniel L. FlynnBryan D. SmithMingfu WangYanguo Hong
- Cited by
- HematologyGeneticsOncology
- Journals
- Cancer Research (11 papers)Blood (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)
- Partner nations
- United StatesSwitzerland
In The Last Decade
Scott Wise
39 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 91
- Hematology 157
- Genetics 126
- Oncology 293
- Cancer Research 161
- Molecular Biology 660
Countries citing papers authored by Scott Wise
This map shows the geographic impact of Scott Wise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Wise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Wise more than expected).
Fields of papers citing papers by Scott Wise
This network shows the impact of papers produced by Scott Wise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Wise. The network helps show where Scott Wise may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Scott Wise, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2022 | 19 | |
| 3 | 2022 | 7 | |
| 4 | 2021 | 40 | |
| 5 | 2017 | 105 | |
| 6 | 2017 | 3 | |
| 7 | 2016 | 31 | |
| 8 | 2016 | 1 | |
| 9 | 2012 | 25 | |
| 10 | 2011 | 77 | |
| 11 | 2010 | 26 | |
| 12 | 2010 | 71 | |
| 13 | 2008 | 7 | |
| 14 | Activation switch pocket inhibitors target the T315I mutant of BCR-ABL | 2008 | 1 |
| 15 | 2007 | 3 | |
| 16 | 2000 | 192 | |
| 17 | 1999 | 183 | |
| 18 | 1998 | 30 | |
| 19 | 1996 | 91 | |
| 20 | 1955 | 30 |
About Scott Wise
Scott Wise is a scholar working on Hematology, Genetics and Rheumatology, having authored 43 papers that have together received 1.2k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (10 papers), Chronic Lymphocytic Leukemia Research (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Ferroptosis and cancer prognosis (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Musculoskeletal synovial abnormalities and treatments (3 papers) and Nanoplatforms for cancer theranostics (3 papers). The work is most often cited by research in Hematology (157 citations), Genetics (126 citations) and Oncology (293 citations). Scott Wise has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Todd Leff, Michael J. Birrer, Powel H. Brown, Anita L. Sabichi, Daniel L. Flynn, Bryan D. Smith, Mingfu Wang, Yanguo Hong, Xun Shen and Heidi S. Camp. Their work appears in journals such as Cancer Research, Blood, Bioorganic & Medicinal Chemistry Letters, Journal of Clinical Oncology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.